AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Redcare Pharmacy N.V.

Report Publication Announcement Mar 17, 2025

6219_rns_2025-03-17_1fc2cbc0-8680-44a3-bfc7-536068abf93e.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

News Details

Advance financial reports | 17 March 2025 18:07

Redcare Pharmacy N.V.: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Redcare Pharmacy N.V. / Preliminary announcement on the disclosure of financial statements

Redcare Pharmacy N.V.: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

17.03.2025 / 18:07 CET/CEST

Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News – a service of EQS Group.

The issuer is solely responsible for the content of this announcement.


Redcare Pharmacy N.V. hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report of the group

Language: English

Date of disclosure: March 11, 2025

Address: https://ir.redcare-pharmacy.com/event-and-publication

Report Type: Financial report of the group (half-year/Q2)

Language: English

Date of disclosure: July 29, 2025

Address: https://ir.redcare-pharmacy.com/event-and-publication


17.03.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Internet: www.redcare-pharmacy.com
End of News EQS News Service

2101896  17.03.2025 CET/CEST

Talk to a Data Expert

Have a question? We'll get back to you promptly.